The video examines how cooperation is rapidly replacing competition in the cardiovascular world, as both surgeons and interventionalists are signing on to the "heart team" for treatment of patients with stable coronary disease.
“When I would go to heart conferences back in the 80’s, there used to be a real battle about bypass surgery versus stenting between cardiac surgeons and interventionalists,” says Dr. Marshall, who is also president-elect of the Society of Cardiovascular Angiography and Interventions (SCAI).
He says the shift from turf wars to teamwork really started with the SYNTAX trial, which assessed outcomes in patients with complex coronary disease who were treated with either bypass surgery or stenting-based. That trial required pretreatment assessment by a “heart team” which included surgeons, interventional cardiologists, and general cardiologists.
Now the lessons from SYNTAX -- including the use of the SYNTAX risk score -- have been codified into new revascularization guidelines issued by the American College of Cardiology and American Heart Association.
“These guidelines are the consecration of the heart team approach as a Class 1 recommendation,” says Dr. Marshall.
In the video, Dr. Marshall is interviewed by Peggy Peck, MedPage Today’s executive editor. It was recorded during a break in sessions at the Transcatheter Cardiovascular Therapeutics meeting, which was held November 7 – 11 in San Francisco.